Works matching DE "HEPATITIS C treatment"

Results: 2936
    1
    2
    3
    4
    5

    The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real‐life experience.

    Published in:
    Liver International, 2018, v. 38, n. 4, p. 733, doi. 10.1111/liv.13588
    By:
    • the ITACOPS study group;
    • Martini, Silvia;
    • Carrai, Paola;
    • Donato, Maria Francesca;
    • Mazzarelli, Chiara;
    • Rendina, Maria;
    • Visco‐Comandini, Ubaldo;
    • Filì, Daniela;
    • Gianstefani, Alice;
    • Caraceni, Paolo;
    • Fagiuoli, Stefano;
    • Melazzini, Mario;
    • Montilla, Simona;
    • Pani, Luca;
    • Petraglia, Sandra;
    • Russo, Pierluigi;
    • Trotta, Maria Paola
    Publication type:
    Article
    6

    Real‐world efficacy and safety of ombitasvir, paritaprevir/r+dasabuvir+ribavirin in genotype 1b patients with hepatitis C virus cirrhosis.

    Published in:
    Liver International, 2018, v. 38, n. 4, p. 602, doi. 10.1111/liv.13550
    By:
    • Preda, Carmen M.;
    • Manuc, Mircea;
    • Gheorghe, Liana;
    • Proca, Doina;
    • Constantinescu, Ileana;
    • Diculescu, Mircea M.;
    • Oproiu, Alexandru;
    • Popescu, Corneliu P.;
    • Ceausu, Emanoil;
    • Ruta, Simona M.;
    • Baicus, Cristian;
    • Voiosu, Theodor A.;
    • Pop, Corina Silvia;
    • Sporea, Ioan;
    • Trifan, Anca;
    • Tantau, Marcel;
    • Tantau, Alina
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14

    High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4.

    Published in:
    Liver International, 2017, v. 37, n. 12, p. 1823, doi. 10.1111/liv.13470
    By:
    • Mariño, Zoe;
    • Pascasio‐Acevedo, Juan M.;
    • Gallego, Adolfo;
    • Diago, Moisés;
    • Baliellas, Carme;
    • Morillas, Rosa;
    • Prieto, Martín;
    • Moreno, José M.;
    • Sánchez‐Antolín, Gloria;
    • Vergara, Mercedes;
    • Forné, Montserrat;
    • Fernández, Inmaculada;
    • Castro, María A.;
    • Pascual, Sonia;
    • Gómez, Alexandra;
    • Castells, Lluis;
    • Montero, José L.;
    • Crespo, Javier;
    • Calleja, José L.;
    • García‐Samaniego, Javier
    Publication type:
    Article
    15
    16
    17

    Daclatasvir plus sofosbuvir, with or without ribavirin, for hepatitis C virus genotype 3 in a French early access programme.

    Published in:
    Liver International, 2017, v. 37, n. 9, p. 1314, doi. 10.1111/liv.13383
    By:
    • Hézode, Christophe;
    • Lebray, Pascal;
    • De Ledinghen, Victor;
    • Zoulim, Fabien;
    • Di Martino, Vincent;
    • Boyer, Nathalie;
    • Larrey, Dominique;
    • Botta ‐ Fridlund, Danielle;
    • Silvain, Christine;
    • Fontaine, Hélène;
    • D'Alteroche, Louis;
    • Leroy, Vincent;
    • Bourliere, Marc;
    • Hubert ‐ Fouchard, Isabelle;
    • Guyader, Dominique;
    • Rosa, Isabelle;
    • Nguyen ‐ Khac, Eric;
    • Fedchuk, Larysa;
    • Akremi, Raoudha;
    • Bennai, Yacia
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24
    25

    Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: a real-life strategy.

    Published in:
    Liver International, 2017, v. 37, n. 5, p. 678, doi. 10.1111/liv.13322
    By:
    • Donato, Maria Francesca;
    • Morelli, Cristina;
    • Romagnoli, Renato;
    • Invernizzi, Federica;
    • Mazzarelli, Chiara;
    • Iemmolo, Rosa Maria;
    • Montalbano, Marzia;
    • Lenci, Ilaria;
    • Bhoori, Sherrie;
    • Pieri, Giulia;
    • Berardi, Sonia;
    • Caraceni, Paolo;
    • Martini, Silvia;
    • Angeli, Paolo;
    • Belli, Luca Saverio;
    • Bernabucci, Veronica;
    • Malinverno, Federica;
    • Monico, Sara;
    • Ottobrelli, Antonio;
    • Romano, Antonietta
    Publication type:
    Article
    26

    Efficacy and safety of sofosbuvir/simeprevir plus flat dose ribavirin in genotype 1 elderly cirrhotic patients: A real-life study.

    Published in:
    Liver International, 2017, v. 37, n. 5, p. 653, doi. 10.1111/liv.13288
    By:
    • Pellicelli, Adriano M.;
    • Pace Palitti, Valeria;
    • Vignally, Pascal;
    • Ceccherini ‐ Silberstein, Francesca;
    • Siciliano, Massimo;
    • Giannelli, Valerio;
    • Moretti, Alessandra;
    • Tarquini, Pierluigi;
    • Scifo, Gaetano;
    • Messina, Vincenzo;
    • Ascione, Antonio;
    • Izzi, Antonio;
    • Marignani, Massimo;
    • D'Ambrosio, Cecilia;
    • Fondacaro, Lucia;
    • Ettorre, Giuseppe M.;
    • Ialongo, Pasquale;
    • Sacco, Rodolfo;
    • Perno, Carlo F.;
    • Barbarini, Giorgio
    Publication type:
    Article
    27
    28

    Real life Egyptian experience of efficacy and safety of Simeprevir/Sofosbuvir therapy in 6211 chronic HCV genotype IV infected patients.

    Published in:
    Liver International, 2017, v. 37, n. 4, p. 534, doi. 10.1111/liv.13266
    By:
    • Eletreby, Rasha;
    • Elakel, Wafaa;
    • Said, Mohamed;
    • El Kassas, Mohamed;
    • Seif, Sameh;
    • Elbaz, Tamer;
    • El Raziky, Maissa;
    • Abdel Rehim, Siham;
    • Zaky, Samy;
    • Fouad, Rabab;
    • Gamal Eldeen, Hadeel;
    • Abdo, Mahmoud;
    • Korany, Mohamed;
    • Yosry, Ayman;
    • El Serafy, Magdy;
    • El ‐ Sayed, Manal Hamdy;
    • ElShazly, Yehia;
    • Waked, Imam;
    • Doss, Wahid;
    • Esmat, Gamal
    Publication type:
    Article
    29

    Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies.

    Published in:
    Liver International, 2017, v. 37, n. 4, p. 514, doi. 10.1111/liv.13327
    By:
    • Di Maio, Velia C.;
    • Cento, Valeria;
    • Lenci, Ilaria;
    • Aragri, Marianna;
    • Rossi, Piera;
    • Barbaliscia, Silvia;
    • Melis, Michela;
    • Verucchi, Gabriella;
    • Magni, Carlo F.;
    • Teti, Elisabetta;
    • Bertoli, Ada;
    • Antonucci, FrancescoPaolo;
    • Bellocchi, Maria C.;
    • Micheli, Valeria;
    • Masetti, Chiara;
    • Landonio, Simona;
    • Francioso, Simona;
    • Santopaolo, Francesco;
    • Pellicelli, Adriano M.;
    • Calvaruso, Vincenza
    Publication type:
    Article
    30
    31
    32
    33

    Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosis.

    Published in:
    Liver International, 2017, v. 37, n. 1, p. 62, doi. 10.1111/liv.13193
    By:
    • Martini, Silvia;
    • Sacco, Marco;
    • Strona, Silvia;
    • Arese, Daniele;
    • Tandoi, Francesco;
    • Dell Olio, Dominic;
    • Stradella, Davide;
    • Cocchis, Donatella;
    • Mirabella, Stefano;
    • Rizza, Giorgia;
    • Magistroni, Paola;
    • Moschini, Pamela;
    • Ottobrelli, Antonio;
    • Amoroso, Antonio;
    • Rizzetto, Mario;
    • Salizzoni, Mauro;
    • Saracco, Giorgio M.;
    • Romagnoli, Renato
    Publication type:
    Article
    34
    35
    36
    37
    38
    39

    Apolipoprotein E allele frequencies in chronic and self-limited hepatitis C suggest a protective effect of APOE4 in the course of hepatitis C virus infection.

    Published in:
    Liver International, 2016, v. 36, n. 9, p. 1267, doi. 10.1111/liv.13094
    By:
    • Mueller, Tobias;
    • Fischer, Janett;
    • Gessner, Reinhard;
    • Rosendahl, Jonas;
    • Böhm, Stephan;
    • Bömmel, Florian;
    • Knop, Viola;
    • Sarrazin, Christoph;
    • Witt, Heiko;
    • Marques, Andreas Mas;
    • Kovacs, Peter;
    • Schleinitz, Dorit;
    • Stumvoll, Michael;
    • Blüher, Matthias;
    • Bugert, Peter;
    • Schott, Eckart;
    • Berg, Thomas
    Publication type:
    Article
    40
    41
    42
    43
    44

    Generic medications for hepatitis C.

    Published in:
    Liver International, 2016, v. 36, n. 7, p. 925, doi. 10.1111/liv.13120
    By:
    • Jensen, Donald M.;
    • Sebhatu, Phoebe;
    • Reau, Nancy S.
    Publication type:
    Article
    45

    Daclatasvir plus asunaprevir for HCV genotype 1b infection in patients with or without compensated cirrhosis: a pooled analysis.

    Published in:
    Liver International, 2016, v. 36, n. 7, p. 954, doi. 10.1111/liv.13049
    By:
    • Kao, Jia ‐ Horng;
    • Jensen, Donald M.;
    • Manns, Michael P.;
    • Jacobson, Ira;
    • Kumada, Hiromitsu;
    • Toyota, Joji;
    • Heo, Jeong;
    • Yoffe, Boris;
    • Sievert, William;
    • Bessone, Fernando;
    • Peng, Cheng ‐ Yuan;
    • Roberts, Stuart K.;
    • Lee, Youn ‐ Jae;
    • Bhore, Rafia;
    • Mendez, Patricia;
    • Hughes, Eric;
    • Noviello, Stephanie
    Publication type:
    Article
    46
    47

    Daclatasvir + asunaprevir + beclabuvir ± ribavirin for chronic HCV genotype 1-infected treatment-naive patients.

    Published in:
    Liver International, 2016, v. 36, n. 2, p. 189, doi. 10.1111/liv.12964
    By:
    • Everson, Gregory T.;
    • Sims, Karen D.;
    • Thuluvath, Paul J.;
    • Lawitz, Eric;
    • Hassanein, Tarek;
    • Rodriguez ‐ Torres, Maribel;
    • Desta, Tadesse;
    • Hawkins, Trevor;
    • Levin, James M.;
    • Hinestrosa, Federico;
    • Rustgi, Vinod;
    • Schwartz, Howard;
    • Younossi, Zobair;
    • Webster, Lynn;
    • Gitlin, Norman;
    • Eley, Timothy;
    • Huang, Shu ‐ Pang;
    • McPhee, Fiona;
    • Grasela, Dennis M.;
    • Gardiner, David F.
    Publication type:
    Article
    48
    49
    50